![\"\"](\"http:\/\/www.fedaiisf.it\/wp-content\/uploads\/2018\/01\/MedsAEcarter2018-300x125.jpg\")
<\/a>This is the list of 90 active ingredients whose risk\/benefit balance is unfavorable and their use should be avoided despite their authorization in France or in the European Union.
\nThe analysis was conducted over eight years, between 2010 and today, and brings to light many more dangerous than useful drugs. This study was conducted with the aim of "helping to choose quality care, first of all so as not to harm patients and to avoid harm", explains Prescrire.<\/p>\nThe evaluation of the drugs was carried out on various criteria, efficacy data, reference to the reference treatment, determination of the most relevant clinical evaluation criteria for the patients and their undesirable effects. This blacklist highlights the use of antiemetics such as Vogalene or Motilium or vasoconstrictors such as Dolirhume or Xylocaine. These drugs are often used to combat a sinusitis or a cold as they are likely to trigger potentially fatal cardiovascular problems. Anti-inflammatories such as Ketum, Voltaflex and Voltarene are also dangerous.<\/p>\n
THE MEDICINAL PRODUCTS CONCERNED (names are translated from French, we apologize for any inaccuracies)<\/strong><\/p>\nOncology \u2013 Hematology: Defibrotide, mifamurtide, nint\u00e9danib, olaparib, panobinostat, trabectedin, vandetanib, vinflunine.<\/p>\n
Cardiology: aliskiren, bezafibrate, ciprofibrate, fenofibrate, dronedarone, ivabradine, nicorandil, olmesartan, ranolazine, trimetazidine, vernakalant.
\nDermatology and Allergology: mequitazine, promethazine, dermal Tacrolimus.<\/p>\n
Diabetology-Nutrition: Alogliptin, linagliptin, saxagliptin, sitagliptin, vildagliptin, pioglitazone, the combination of bupropion + naltrexone, orlistat.<\/p>\n
Pain \u2013 Rheumatology:
\ncelecoxib, etoricoxib, parecoxib, aceclofenac, diclofenac, ketoprofen gel, piroxicam, diacerein, glucosamine, capsaicin, denosumab dosed at 60mg, methocarbamol, thiocolchicoside, quinine, colchicine + opium powder + thiemonium combination, prednisolone + dipropylene glycol salicylate combination.<\/p>\n
Gastroenterology:
\ndomperidone, droperidol, metopimazine, nifuroxazide, prucalopride<\/p>\n
Gynecology and Endocrinology: Combination dose conjugated equine estrogen + bazedoxifene
\ntibolone.<\/p>\n
Infectious diseases: moxifloxacin, telithromycin.<\/p>\n
Neurology: donepezil, galantamine, rivastigmine, memantine, alemtuzumab, natalizumab, teriflunomide, flunarizine, oxetorone, tolcapone.<\/p>\n
ophthalmology: cyclosporine eye drops, Idebenone.<\/p>\n
ENT pneumology: ephedrine, naphazoline, oxymetazoline, phenylephrine, pseudo ephedrine, tuaminoheptane, ambroxol, bromhexine, pholcodine, Tixocortol oral spray, mannitol inhalation, nint\u00e9danib, roflumilast, selexipag<\/p>\n
Psychiatry \u2013 Addiction: agomelatine, duloxetine, citalopram, escitalopram, milnacipran, venlafaxine, tianeptine, dapoxetine, etifoxine, bupropion.<\/p>\n
Related news: Pour mieux soigner, des m\u00e9dicaments \u00e0 \u00e9carter : balance sheet 2018<\/a><\/p>","protected":false},"excerpt":{"rendered":"Tutti i nomi dei principi attivi pericolosi Molti dalla provincia di Imperia si recano nella vicina Francia per comprare medicine. Un po\u2019 perch\u00e9 alcuni costano di meno che in Italia, un po\u2019 perch\u00e9 vengono considerati (spesso senza fondamento scientifico) pi\u00f9 efficaci che le loro controparti del Belpaese. Attenzione per\u00f2. Si perch\u00e9, secondo quando riporta Nice …<\/p>","protected":false},"author":4,"featured_media":34503,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[29],"class_list":["post-34498","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-notizie","tag-prezzo-farmaci"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/34498","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=34498"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/34498\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/34503"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=34498"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=34498"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=34498"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
![\"\"](\"http:\/\/www.fedaiisf.it\/wp-content\/uploads\/2018\/01\/MedsAEcarter2018.jpg\")
<\/a>This is the list of 90 active ingredients whose risk\/benefit balance is unfavorable and their use should be avoided despite their authorization in France or in the European Union.